Technical Analysis for IGMS - IGM Biosciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 8.33 | -4.36% | -0.38 |
IGMS closed down 4.36 percent on Friday, May 31, 2024, on 75 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Jun 11
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 0.00% | |
| MACD Bearish Centerline Cross | Bearish | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 50 DMA Resistance | Bearish | -4.36% | |
| 180 Bearish Setup | Bearish Swing Setup | -4.36% |
| Alert | Time |
|---|---|
| Down 5% | 1 day ago |
| Down 3% | 1 day ago |
| Fell Below 200 DMA | 1 day ago |
| Down 2 % | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/11/2024
Headquartered in Mountain View, California, IGM Biosciences is a biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunology Antibodies Treatment Of Cancer Glycoproteins Biochemistry Protein Engineering Immunoglobulin M
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunology Antibodies Treatment Of Cancer Glycoproteins Biochemistry Protein Engineering Immunoglobulin M
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.7 |
| 52 Week Low | 3.81 |
| Average Volume | 319,973 |
| 200-Day Moving Average | 8.54 |
| 50-Day Moving Average | 9.06 |
| 20-Day Moving Average | 9.43 |
| 10-Day Moving Average | 9.24 |
| Average True Range | 1.00 |
| RSI (14) | 43.50 |
| ADX | 16.8 |
| +DI | 28.08 |
| -DI | 23.26 |
| Chandelier Exit (Long, 3 ATRs) | 9.31 |
| Chandelier Exit (Short, 3 ATRs) | 11.04 |
| Upper Bollinger Bands | 10.86 |
| Lower Bollinger Band | 7.99 |
| Percent B (%b) | 0.12 |
| BandWidth | 30.39 |
| MACD Line | -0.08 |
| MACD Signal Line | 0.03 |
| MACD Histogram | -0.1079 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.51 | ||||
| Resistance 3 (R3) | 9.59 | 9.27 | 9.31 | ||
| Resistance 2 (R2) | 9.27 | 8.97 | 9.23 | 9.25 | |
| Resistance 1 (R1) | 8.80 | 8.79 | 8.65 | 8.72 | 9.18 |
| Pivot Point | 8.49 | 8.49 | 8.41 | 8.45 | 8.49 |
| Support 1 (S1) | 8.02 | 8.19 | 7.86 | 7.94 | 7.48 |
| Support 2 (S2) | 7.70 | 8.00 | 7.66 | 7.41 | |
| Support 3 (S3) | 7.23 | 7.70 | 7.35 | ||
| Support 4 (S4) | 7.15 |
